샘플 요청 목록

 카트 문의
시장보고서
상품코드
1439957

정형외과 임플란트 : 세계 시장 인사이트, 경쟁 구도, 시장 예측(2030년)

Orthopedic Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 정형외과 임플란트 시장 규모는 2024-2030년의 예측 기간에 CAGR로 5.46%의 성장이 전망됩니다. 시장은 관절염, 골다공증 등 정형외과 질환의 유병률 증가, 노년 인구의 부담 증가, 교통사고 및 기타 부상의 증가, 정형외과 임플란트의 안전성, 가용성, 사용 편의성의 향상에 대한 주목의 증가 등의 요인에 의해 호황이 전망되며, 예측 기간(2024-2030년)에 시장에서 큰 매출 성장이 전망됩니다.

정형외과 임플란트 시장 역학

세계보건기구(WHO)(2022)에 따르면 근골격계 질환은 장애의 주요 원인으로, 전 세계에서 약 17억 1,000만 명이 골다공증, 골관절염, 류마티스 관절염 등 근골격계 질환을 앓고 있다고 합니다.

퇴행성 관절염 또는 마모성 관절염으로도 알려진 퇴행성 관절염은 관절에 영향을 미치고 시간이 지남에 따라 뼈 표면에서 부드러운 연골이 마모되는 질환입니다. 이로 인해 환자는 관절의 염증, 부종 및 통증에 직면하여 사람의 전반적인 움직임에 영향을 미칩니다. 심한 경우 환자는 정형외과 임플란트 수술을 받아야 합니다.

세계보건기구(WHO)에 따르면 2019년 전 세계 약 5억 2,800만 명이 골관절염을 앓고 있다고 합니다. 같은 자료에 따르면 2019년 전 세계 1,800만 명이 류마티스 관절염을 앓고 있는 것으로 나타났습니다.

또한 위 자료에 따르면 2019년 골관절염은 1,900만 YLD(years lived with disability)에 기여했고, 류마티스 관절염은 전 세계에서 240만 YLD에 기여했습니다.

교통사고 증가는 정형외과 임플란트 시장의 성장을 가속하는 주요 요인입니다. WHO(2022)에 따르면 매년 약 130만 명이 교통사고로 인해 사망하고 약 2,000만-5,000만 명이 치명적이지 않은 부상이나 장애를 입다고 합니다. 치명적이지 않은 부상이나 장애를 입고 있습니다.

그러나 높은 수술 비용과 재수술의 필요성, 정형외과 임플란트에 대한 엄격한 규제 승인은 정형외과 임플란트 시장의 성장을 저해하는 요인으로 작용할 수 있습니다.

COVID-19 팬데믹은 정형외과 임플란트 시장에 약간의 영향을 미치고 있습니다. 전염병의 발생으로 인해 외래 진료가 취소되고 긴급하지 않은 병원과 시술이 중단되었습니다. 그 결과, 정형외과 검사와 시술이 감소했습니다. 경제협력개발기구(OECD) 통계(2023년)에 따르면 2019년 대비 2020년 아일랜드와 이탈리아의 고관절 치환술 건수는 20% 가까이 감소했고, 노르웨이와 체코는 10% 이상 감소했습니다. 또한 COVID-19 팬데믹 기간 중 정형외과용 임플란트 제조, 수출입 및 기타 관련 활동도 위축되었습니다. 그러나 COVID-19 백신 개발로 인해 봉쇄령이 완화되고 경제 상황이 정상화되면서 외래 진료 등 정상적인 의료 서비스가 재개되고 정형외과 임플란트 시장의 제품 수요가 회복되는 등 경제 회복 과정이 시작되고 있습니다.

정형외과용 임플란트 시장 부문 분석

정형외과용 임플란트 제품 유형 부문에서는 무릎 관절 임플란트 카테고리가 예측 기간(2024-2030년) 동안 전체 시장에서 큰 폭의 매출 성장을 기록할 것으로 예상됩니다.

무릎 관절 임플란트는 골질환이나 부상으로 인한 통증을 줄이는 경향이 있으며, 무릎 주사, 항염증제 등 비수술적 치료보다 환자에게 충분한 구호를 제공합니다.

무릎 인공관절 치환술 후 환자들은 통증, 이동성, 삶의 질(QOL)이 개선됩니다. 일상 생활에 지장 없이 복귀할 수 있습니다.

2022년 경제협력개발기구(OECD) 통계에 따르면 2019년 인구 10만 명당 스위스 약 260건, 독일 227건, 호주 211건, 한국 153건, 영국 142건의 무릎 인공관절 치환술이 시행되었습니다. 이 자료에 따르면 2019년 무릎 인공관절 치환술 평균은 인구 10만 명당 137건이었습니다. 임플란트 재료, 디자인, 수술 기법의 새로운 기술 발전으로 무릎 인공관절 수명이 약 10-15년 정도 연장되고 있습니다.

세계의 정형외과 임플란트 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인과 과제, 기업과 제품의 개요 등을 제공하고 있습니다.

목차

제1장 정형외과 임플란트 시장 보고서의 서론

제2장 정형외과 임플란트 시장의 주요 요약

  • 조사 범위
  • 시장의 개요
  • 경쟁의 평가

제3장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제4장 정형외과 임플란트 시장의 주요 요인 분석

  • 정형외과 임플란트 시장 촉진요인
  • 정형외과 임플란트 시장 억제요인과 과제
  • 정형외과 임플란트 시장의 기회

제5장 정형외과 임플란트 시장 Porter's Five Forces 분석

제6장 정형외과 임플란트 시장에 대한 COVID-19의 영향 분석

제7장 정형외과 임플란트 시장 레이아웃

  • 제품 유형
    • 고관절 임플란트
    • 슬관절 임플란트
    • 척추 임플란트
    • 발, 발목 임플란트
    • 기타
  • 최종사용자별
    • 병원
    • 정형외과 클리닉
  • 지역
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 정형외과 임플란트 시장의 기업과 제품 개요

  • Zimmer Biomet
  • Stryker
  • Johnson & Johnson Services, Inc.
  • Biotek(Chetan Meditech Pvt. Ltd.)
  • CONMED Corporation
  • Medtronic
  • Enovis
  • Smith+Nephew
  • B. Braun SE
  • Exactech, Inc.
  • Corin Group
  • Conformis
  • Medacta International
  • Globus Medical
  • Arthrex, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Auxein Medical
  • United Orthopedic Corporation
  • Limacorporate S.p.A.
  • NuVasive®, Inc.

제9장 KOL의 견해

제10장 프로젝트 어프로치

제11장 DelveInsight 소개

제12장 면책사항과 문의

KSA 24.04.08

Orthopedic Implants Market By Product Type (Hip Implants, Knee Implants, Spinal Implants, Foot And Ankle Implants, And Others), By End-User (Hospitals, Orthopedic Clinics, And Others ), by geography is estimated to register growth at a remarkable CAGR forecast during 2024-2030 owing to increasing prevalence of orthopedic diseases and rising demand for personalized orthopedic implants

The global orthopedic implants market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030. The orthopedic implants market is slated to witness prosperity owing to factors such as the increasing prevalence of orthopedic diseases such as arthritis, osteoporosis, and others, a growing burden of the geriatric population, the rising number of road accidents associated and other injuries, and the growing focus on improving the safety, affordability, and usability of orthopedic implants for people are further expected to result in the appreciable revenue growth in the orthopedic implants market during the forecast period (2024-2030).

Orthopedic Implants Market Dynamics:

According to World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability, and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others.

Osteoarthritis also known as degenerative or wear-and-tear arthritis affects the joints and with time leads to the wearing off of smooth cartilage from the surface of bones. This causes patients to face inflammation, swelling, and pain in joints affecting the overall movement of a person. In severe cases, patients have to undergo orthopedic implant surgery.

According to World Health Organization 2022, worldwide around 528 million people suffered from osteoarthritis in 2019. As per the same source, worldwide 18 million people had rheumatoid arthritis in 2019.

Also, according to the above-mentioned source osteoarthritis contributed to 19 million years lived with disability (YLDs), while rheumatoid arthritis contributed to 2.4 million YLDs globally in 2019.

The rise in road traffic accidents is another major factor driving the growth of the orthopedic implants market. Light and fatal injuries owing to sudden road accidents lead to disability sometimes and increase the need for orthopedic implants, positively impacting the growth of the orthopedic implants market. According to WHO 2022, approximately 1.3 million people die each year because of road traffic accidents and around 20-50 million individuals suffer from non-fatal injuries or some sort of disability.

However, the high cost of the procedure coupled with the need to undergo revision surgery and stringent regulatory approval for orthopedic implants may act as a restraint in the market growth for orthopedic implants.

The COVID-19 pandemic has slightly impacted the market for orthopedic implants. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and procedures. This resulted in a reduced number of orthopedic examinations and procedures. As per Organization for Economic Cooperation and Development (OECD) statistics (2023), a nearly 20% drop in hip replacements was observed in 2020 in Ireland and Italy, and a more than 10% drop in Norway and the Czech Republic compared to 2019. Also, the manufacturing, import, export, and other related activities of orthopedic implants were hampered during the period of COVID- 19 pandemic. However, the vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits, thereby bringing the demand for products on track in the orthopedic implants market.

Orthopedic Implants Market Segment Analysis:

Orthopedic Implants Market by Product Type (Hip Implants, Knee Implants, Spinal Implants, Foot and Ankle Implants, and Others), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Based on the product type segment of orthopedic implants, the knee implants category is projected to register a significant growth in revenue in the overall orthopedic implants market during the forecast period (2024-2030).

Knee implants tend to reduce the pain due to any bone disease or injury and provide adequate relief to the patient over non-operative treatments such as knee injections, anti-inflammatory medications, and others.

Post-knee implantation patients witness improvements in pain, mobility, and quality of life. They can return to doing day-to-day tasks without much hindrance.

As per Organization for Economic Cooperation and Development (OECD) statistics for 2022, about 260 knee replacement surgeries in Switzerland, 227 in Germany, 211 in Australia, 153 in Korea, and 142 in the United Kingdom, per 100,000 population were performed in 2019. As per the same source, the average for knee replacement surgery was 137 per 100,000 population in 2019. The newer technological advancements in implant material, design, and surgical technique have facilitated in increasing the longevity of knee implants by about 10-15 years.

Thereby, considering the growing demand for this product type, numerous new products are being developed and launched in the market. For example, in November 2022, Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, obtained 510(k) clearance from the US Food and Drug Administration to market the TriVerse(TM) primary knee system.

Therefore, considering the advantages associated with knee implants and their growing popularity, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global orthopedic implants market during the forecast period.

North America is expected to dominate the overall Orthopedic Implants Market:

Among all the regions, North America is expected to lead in revenue generation in the global orthopedic implants market. This can be due to factors including the prevalence of chronic bone diseases, the increasing old age population, and the presence of key companies involved in the production of orthopedic implants, high-tech medical facilities, and others.

One of the prominent factors supporting the growth of the North America orthopedic implants market is the prevalence of chronic bone diseases leading to disability, majorly in the United States. The rising prevalence of arthritis in the US is the major factor responsible for the growth of the orthopedic implants market in the region. As per the Centers for Disease Control and Prevention (CDC) 2022, it has been estimated that there will be around 78.4 million people suffering from doctor-diagnosed arthritis by 2040, and out of that two-thirds will be the women population.

As per the same source, an estimated 34.6 million adults will face arthritis-attributable activity limitations in the US by 2040. As per Arthritis Foundation 2022, around 1.5 million people have rheumatoid arthritis in the United States.

The increasing age makes one susceptible to several health issues including bone diseases, and others, and thus is another driver for the growth of the orthopedic implants market. According to CDC 2022, around 54.1 million US adults were aged 65 or older in 2019. As per the same source, it has been estimated that by 2060, this number will reach up to 94.7 million in the US. Along with the presence of a large patient pool in the country, the increasing focus of manufacturers on launching new products in the market is expected to bolster the growth of the orthopedic implants market in the United States during the forecast period.

For example, in February 2020, In2Bones Global, Inc. received the US Food and Drug Administration clearance to market the Quantum(TM) Total Ankle Replacement System. Therefore, the above-mentioned factors are expected to bolster the growth of the orthopedic implants market in the United States during the forecast period.

Orthopedic Implants Market Key Players:

Some of the key market players operating in the orthopedic implants market include Smith+Nephew, Stryker, Zimmer Biomet, Johnson & Johnson Services, Inc.Biotek (Chetan Meditech Pvt. Ltd.), CONMED Corporation, Medtronic, Enovis, B. Braun SE, Corin Group, Exactech, Inc., Meril Life Sciences Pvt. Ltd., Arthrex, Inc., Conformis, Medacta International, Globus Medical, Auxein Medical, United Orthopedic Corporation, Limacorporate S.p.A., NuVasive®, Inc., and others.

Recent Developmental Activities in the Orthopedic Implants Market:

In September 2022, Zimmer Biomet Holdings, Inc., a global medical technology leader, received the US Food and Drug Administration (FDA) 510(k) clearance of the Identity(TM) Shoulder System for anatomic, reverse, and revision shoulder replacement.

In September 2022, Tyber Medical, LLC, a leading orthopedic device manufacturer providing private-label ORTHOPEDIC Implants for the trauma, extremity, and spine markets, received its second and largest US FDA 510(k) clearance for its expanded line of anatomical plating systems.

In July 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal healing products received the US FDA 510(k) clearance and European CE Mark approval for the JuniOrtho® Plating System which is designed to address the demands of advanced deformity and trauma reconstruction of the lower extremities.

Key Takeaways from the Orthopedic Implants Market Report Study

Market size analysis for current orthopedic implants market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the orthopedic implant market.

Top key product developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years

Key companies dominating the global orthopedic implants market.

Various opportunities available for the other competitor in the orthopedic implants market space.

What are the top-performing segments in 2023? How these segments will perform in 2027?

Which are the top-performing regions and countries in the current orthopedic implants market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for orthopedic implants market growth in the coming future?

Target Audience who can be benefited from this Orthopedic Implants Market Report Study

Orthopedic implants products providers

Research organizations and consulting companies

Orthopedic Implants -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in orthopedic implants

Various distribution channels who want to know more about the orthopedic implants market and the latest product innovations in the orthopedic Implants market.

Frequently Asked Questions for the Orthopedic Implants Market:

1. What are orthopedic implants?

Orthopedic implants are intended for the replacement of a joint, bone, or cartilage owing to some damage or deformity that happened due to any disease or injury and include knee, shoulder, hip, foot, and ankle implants among others.

2. What is the market for global orthopedic Implants?

The global orthopedic implants market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030.

3. What are the drivers for the global orthopedic implants market?

The orthopedic implants market is slated to witness prosperity owing to factors such as the increasing prevalence of orthopedic diseases, rising cases of road accidents and other traumatic injuries, the growing burden of the geriatric population, increasing demand for personalized orthopedic implants, rising technological advancements, and the growing focus on improving the safety and usability of orthopedic implants for people are further expected to result in the appreciable revenue growth in the orthopedic implants market during the forecast period (2024-2030).

4. Who are the key players operating in the global orthopedic implants market?

Some of the key market players operating in the orthopedic implants market include Smith+Nephew, Stryker, Zimmer Biomet, Johnson & Johnson Services, Inc.Biotek (Chetan Meditech Pvt. Ltd.), CONMED Corporation, Medtronic, Enovis, B. Braun SE, Corin Group, Exactech, Inc., Meril Life Sciences Pvt. Ltd., Arthrex, Inc., Conformis, Medacta International, Globus Medical, Auxein Medical, United Orthopedic Corporation, Limacorporate S.p.A., NuVasive®, Inc., and others.

5. Which region has the highest share in the orthopedic implants market?

North America is expected to dominate the overall orthopedic implants market during the forecast period, 2024 to 2030. This can be ascribed to the increasing patient population suffering from orthopedic implants for regular household cleaning and sanitation activities and for maintaining personal hygiene, increasing disposable personal income, and a highly potent market in terms of product development and launches, and the local presence of key market players among other factors in the region.

Table of Contents

1.Orthopedic Implants Market Report Introduction

2. Orthopedic Implants Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Orthopedic Implants Market Key Factors Analysis

  • 4.1. Orthopedic Implants Market Drivers
    • 4.1.1. Increasing prevalence of orthopedic diseases
    • 4.1.2. Rising number of road accidents and other traumatic injuries
    • 4.1.3. The growing burden of the geriatric population
  • 4.2. Orthopedic Implants Market Restraints and Challenges
    • 4.2.1. High cost of procedures coupled with the need to undergo revision surgery
    • 4.2.2. Stringent regulatory policies for orthopedic implants
  • 4.3. Orthopedic Implants Market Opportunities
    • 4.3.1. Increasing demand for personalized orthopedic implants
    • 4.3.2. The growing concept of smart orthopedic implants

5. Orthopedic Implants Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Orthopedic Implants Market

7. Orthopedic Implants Market Layout

  • 7.1. By Product Type
    • 7.1.1. Hip Implants
    • 7.1.2. Knee Implants
    • 7.1.3. Spinal Implants
    • 7.1.4. Foot and Ankle Implants
    • 7.1.5. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals
    • 7.2.2. Orthopedic Clinics
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.1.2. Canada Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.1.3. Mexico Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.2.2. Germany Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.2.4. Italy Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.2.5. Spain Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.3.2. Japan Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.3.3. India Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.3.4. Australia Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.3.5. South Korea Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.3.6. Rest of the Asia Pacific Orthopedic Implants Market in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.4.2. Africa Orthopedic Implants Market in USD million (2021-2030)
      • 7.3.4.3. South America Orthopedic Implants Market in USD million (2021-2030)

8. Orthopedic Implants Market Company and Product Profiles

  • 8.1. Zimmer Biomet
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Stryker
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Johnson & Johnson Services, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Biotek (Chetan Meditech Pvt. Ltd.)
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. CONMED Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Medtronic
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Enovis
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Smith+Nephew
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. B. Braun SE
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Exactech, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Corin Group
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Conformis
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Medacta International
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Globus Medical
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Arthrex, Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Meril Life Sciences Pvt. Ltd.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Auxein Medical
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. United Orthopedic Corporation
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Limacorporate S.p.A.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. NuVasive®, Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제